Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Big Is The Atrial Fibrillation Market Today And What Is Its Future Size?
The size of the atrial fibrillation market has seen robust growth recently. Projected to expand from $13.56 billion in 2024 to $15.1 billion in 2025, it is set to experience a compound annual growth rate (CAGR) of 11.4%. The remarkable growth during the historic period is due to factors such as enhanced understanding and screening initiatives, advancements in treatment technology, higher healthcare spending, clinical studies, drug development, and genetic predisposition.
In the coming years, the market size for atrial fibrillation is anticipated to witness substantial growth. The projected value is set to reach $24.72 billion by 2029, with a CAGR of 13.1%. The projected growth is attributed to several factors such as the emphasis on stroke prevention, heightened awareness through patient and physician education programs, global efforts towards cardiovascular health, an increase in electrophysiology processes, the development of personalized treatment plans, and government-led initiatives for preventing cardiovascular diseases. Key trends foreseen in this period include the improvement in diagnostic technologies, the escalating incidence of atrial fibrillation, advancements in catheter ablation techniques, the emergence of new oral anticoagulants (NOACs), the incorporation of wearable devices for monitoring, the growing influence of telemedicine in managing AF, and progress in implantable devices.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8007&type=smp
Which Key Factors Are Fueling Growth In The Atrial Fibrillation Market?
The atrial fibrillation market is anticipated to be propelled by the growth in the aging population. This pertains to individuals aged 65 and over, who have a higher likelihood of falling due to various reasons, such as issues with balance or walking and postural hypotension. Factors like aging and conduction disturbances are often visible on the surface electrocardiogram before the onset of Atrial Fibrillation in majority of aged patients. For instance, as per the Swiss-based specialized agency of the United Nations responsible for global public health, World Health Organization, by 2030, six out of every person on the globe will be 60 years old or over. This will take the count to 1.4 billion, an increase from 1 billion in 2020. The global population of individuals aged 60 and above will double, reaching 2.1 billion by 2050. The span between 2020 and 2050 will witness an addition of 426 million people aged 80 or above. Consequently, the escalation in the elderly population is fueling the expansion of the atrial fibrillation market.
How Is The Atrial Fibrillation Market Segmented Across Key Categories?
The atrial fibrillationmarket covered in this report is segmented –
1) By Type: Surgical; Non-Surgical
2) By Technology: Radiofrequency; Laser; Cryotherapy; Other Technologies
3) By Treatment Type: Pharmacological Treatment; Non-pharmacological Treatment; Maze Surgery; Electric Cardioversion
4) By End User: Hospitals; Electrophysiology Labs; Ambulatory Surgical Centers
Subsegments:
1) By Surgical: Catheter Ablation; Maze Procedure; Hybrid Ablation Procedures
2) By Non-Surgical: Antiarrhythmic Drugs; Anticoagulants; Cardioversion Procedures; Device Implants
What Current And Upcoming Trends Are Shaping The Atrial Fibrillation Market?
Leading firms in the atrial fibrillation market are introducing cutting-edge products and solutions such as patient-focused clinical decision support apparatus to solidify their market standing. Clinical decision support apparatus (CDST) is software or digital systems formulated to aid medical professionals in making knowledgeable and prompt decisions regarding patient care. These devices are created to consolidate pertinent clinical data from diverse sources. For instance, in August 2023, GE HealthCare, a multinational medical technology corporation based in the US, introduced CardioVisio, a patient-focused clinical decision support apparatus. This tool aids physicians in implementing evidence-based clinical decision-making inspired by current atrial fibrillation guidelines and in visualizing longitudinal data from several applicable data sources for understanding disease progression. CardioVisio for atrial fibrillation helps cardiologists streamline the interpretation of clinical images and offers a holistic view of the patient’s cardiac history and overall healthcare journey, encompassing past diagnoses, prescribed treatments, interventions, and other existing health conditions.
Who Are The Leading Companies Driving The Atrial Fibrillation Market?
Major companies operating in the atrial fibrillation market are AtriCure Inc., Johnson & Johnson Private Limited, Abbott Laboratories, C.H. Boehringer Sohn AG & Co. KG, Biotronik Se & Co. Kg, Boston Scientific Corporation, Bristol-Myers Squibb Company, CardioFocus Inc., Sanofi S.A, Medtronic PLC, Biosense Webster Inc., MicroPort Scientific Corporation, Siemens AG, Acutus Medical Inc., AEGEA Medical Inc., Apama Medical Inc., Aria CV Inc., Armetheon Inc., BioSig Technologies Inc., Cardialen Inc., CardioRobotics Inc., CardioInsight Technologies Inc., Circa Scientific LLC, CorWave SA, EpiEP Inc., Farapulse Inc., Fibralign Corporation, Impulse Dynamics NV, JenaValve Technology Inc., Kardium Inc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/atrial-fibrillation-global-market-report
Which Region Dominates The Atrial Fibrillation Market Today?
North America was the largest region in the atrial fibrillation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the atrial fibrillation market report forecast period. The regions covered in the atrial fibrillation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=8007&type=smp
Browse Through More Reports Similar to the Global Atrial Fibrillation Market 2025, By The Business Research Company
Arrhythmia Monitoring Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/arrhythmia-monitoring-devices-global-market-report
Cardiac Rhythm Management Crm Devices And Equipment Global Market Report 2025
Cardiac Pacemakers Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cardiac-pacemakers-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model